The brief
- MedTech division is 36% of JNJ revenue; $8.6B sales Q1 2026, up 7.7%.
- Ottava: FDA de novo authorization July 22, 2026 for 10 general surgery procedures.
- Table-integrated design saves 30-50% OR space, automated positioning, Polyphonic digital ecosystem.
Technical approach
Arms built into the surgical table
Four robotic arms fold into the operating table, eliminating boom or cart-mounted structure. Unfold when needed, collapse underneath when not in use.
Software-coordinated procedural poses
Pre-defined positions move arms automatically. Twin Motion synchronizes table and arms for patient repositioning without disrupting the procedure.
Redesigned tools for robotic surgery
Specialized instruments: two-in-one needle driver, monopolar curved scissors optimized for robotic platform.
Polyphonic ecosystem
Ottava connects to J&J's Polyphonic digital platform for data-driven surgical insights, continuous learning and integration with hospital information systems.

